NCT04749394 2022-08-16
A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy
ChineseAMS
Phase 2 Unknown
Clinical Trials
13 trialsNCT04683198 2020-12-24
Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC
ChineseAMS
Phase 2 Unknown
NCT04620837 2020-11-09
Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy
ChineseAMS
Phase 2 Unknown
NCT02995187 2017-09-07
Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
ChineseAMS
Phase 2 Unknown
NCT02960607 2016-11-18
High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC
ChineseAMS
Phase 2 Unknown
NCT02961270 2016-11-11
Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation
ChineseAMS
Phase 2 Unknown
NCT02584699 2015-10-23
Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC
ChineseAMS
Phase 2 Unknown
NCT02323737 2014-12-30
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
ChineseAMS
Phase 2 Completed
NCT00600587 2013-06-25
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)
GuangdongPPH
Phase 2 Completed
NCT01850147 2013-05-09
Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen
ChineseAMS
Phase 2 Unknown
NCT01503385 2012-01-04
Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)
ChineseAMS
Phase 2 Unknown
NCT00663689 2008-04-22
Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer
GuangdongPPH
Phase 2 Unknown
NCT00614809 2008-02-22
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer
GuangdongPPH
Phase 2 Unknown